CR10105A - - Google Patents

Info

Publication number
CR10105A
CR10105A CR10105A CR10105A CR10105A CR 10105 A CR10105 A CR 10105A CR 10105 A CR10105 A CR 10105A CR 10105 A CR10105 A CR 10105A CR 10105 A CR10105 A CR 10105A
Authority
CR
Costa Rica
Application number
CR10105A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CR10105A publication Critical patent/CR10105A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CR10105A 2005-12-20 2008-06-20 CR10105A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA05014090A MXPA05014090A (es) 2005-12-20 2005-12-20 Composiciones farmaceuticas que comprenden sustancias inhibidoras de las lipasas intestinales combinadas con un complejo o- coordinado de dinicotinato de cromo para su uso en el tratamiento y control de la obesidad o sobrepeso.

Publications (1)

Publication Number Publication Date
CR10105A true CR10105A (es) 2008-08-06

Family

ID=38188839

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10105A CR10105A (es) 2005-12-20 2008-06-20

Country Status (6)

Country Link
EP (1) EP1964558A1 (es)
BR (1) BRPI0620105A2 (es)
CR (1) CR10105A (es)
EC (1) ECSP088565A (es)
MX (1) MXPA05014090A (es)
WO (1) WO2007073134A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2471972B1 (en) 2006-12-13 2014-01-29 Idemitsu Kosan Co., Ltd. Sputtering target
RU2008106419A (ru) * 2008-02-21 2009-08-27 Закрытое акционерное общество "Ива фарм" (RU) Лекарственные средства на основе олигоядерных координационных соединений d-металлов, способ терапевтического воздействия на организм пациента и способ повышения терапевтической эффективности фармакологически активного вещества

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612039A (en) * 1994-03-14 1997-03-18 Nini E. Policappelli Dietary supplement
US20040204472A1 (en) * 2003-03-04 2004-10-14 Pharmacia Corporation Treatment and prevention of obesity with COX-2 inhibitors alone or in combination with weight-loss agents

Also Published As

Publication number Publication date
EP1964558A1 (en) 2008-09-03
MXPA05014090A (es) 2007-06-20
ECSP088565A (es) 2008-07-30
BRPI0620105A2 (pt) 2011-11-01
WO2007073134A1 (es) 2007-06-28

Similar Documents

Publication Publication Date Title
BE2025C533I2 (es)
BE2024C510I2 (es)
BE2023C529I2 (es)
BE2021C552I2 (es)
BE2021C557I2 (es)
BE2021C531I2 (es)
BE2021C524I2 (es)
BE2021C519I2 (es)
BE2021C513I2 (es)
BE2020C531I2 (es)
BE2020C511I2 (es)
BE2020C508I2 (es)
BE2020C004I2 (es)
BE2019C521I2 (es)
BE2019C503I2 (es)
BE2018C037I2 (es)
BE2018C035I2 (es)
BE2018C019I2 (es)
BE2018C016I2 (es)
BE2017C028I2 (es)
BE2019C533I2 (es)
BE2017C007I2 (es)
BE2016C045I2 (es)
BE2016C022I2 (es)
BE2015C074I2 (es)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)